Skip to main content

Unable to load price data. Sorry.


Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA.DL)

CAPS Rating: No stars

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:MNTA.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Kanga88 (27.61)
Submitted February 25, 2014

The business proposition and execution of Momenta has been solid, and it is a matter of time that the company will emerge as an innovative leader in the 21st century pharmaceutical industry. Born in the biotech labs of MIT, MNTA has been developing… More

rknapton (< 20)
Submitted August 22, 2013

Short. Pharma company whose revenues are getting slaughtered.



  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about MNTA.DL.

No one has written a Pitch for MNTA.DL stock yet. Tell us why you think MNTA.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in MNTA.DL.

No players have picked MNTA.DL yet. Tell us why you think MNTA.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MNTA.DL.